Edwards Lifesciences Corporation
As of Oct 23, 2026 close
- Market cap
- $51.45B
- P/E (TTM)
- 51.20
- Forward P/E
- 104.25
- Dividend yield
- -
- 52-week range
- $74.66$96.29
- Volume (live)
- -
- Avg. volume (3M)
- 3.57M
Edwards Lifesciences (EW) Stock Price & Financial Analysis
Edwards Lifesciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $88.97 - $91.05 |
|---|---|
| 52-Week High | $96.29 |
| 52-Week Low | $74.66 |
| Open | $90.11 |
| Volume (last close) | 3.10M |
| Average Volume (3M) | 3.57M |
| Revenue (TTM) | 6.51B |
|---|---|
| Net Income (TTM) | 1.00B |
| Free Cash Flow (TTM) | 1.43B |
| EPS (TTM) | $1.73 |
| Profit Margin | 15.43% |
| Operating Margin | 27.43% |
| Return on Equity (ROE) | 9.46% |
| Debt to Equity | 0.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 51.45B |
|---|---|
| Shares Outstanding | 577.60M |
| P/E Ratio (TTM) | 51.20 |
| Forward P/E | 104.25 |
| Price to Sales (P/S) | 7.90 |
| Price to Book (P/B) | 4.85 |
| EV/EBITDA | 29.01 |
| 50-Day MA | $88.29 |
|---|---|
| 200-Day MA | $85.16 |
| 1-Year Change | +17.72% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Edwards Lifesciences at a Glance
As of the Oct 23, 2026 close, Edwards Lifesciences (EW) has a market capitalization of $51.45B. The stock trades at 51.2× trailing earnings, 104.3× forward earnings and 7.9× sales. Over the trailing twelve months it earned $1.00B on revenue of $6.51B (a 15.4% profit margin) and generated $1.43B of free cash flow. Revenue grew 14.6% year over year.
As of its latest reported balance sheet, it holds $2.91B in cash and securities against $622.80M of debt, a net cash position of $2.28B.
Edwards Lifesciences does not currently pay a dividend.
The share price is up 17.7% over the past year. At $89.07 (the Oct 23, 2026 close) it sits within its 52-week range of $74.66 to $96.29, above its 200-day moving average of $85.16.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $104.70, 17.5% above the Oct 23, 2026 close.
Frequently Asked Questions About Edwards Lifesciences
What is the current stock price for EW?
As of the Oct 23, 2026 close, EW stock trades at $89.07. The 52-week range is $74.66–$96.29, with a day range of $88.97–$91.05.
What is the P/E ratio for EW?
As of the Oct 23, 2026 close, Edwards Lifesciences's trailing twelve-month (TTM) P/E ratio is 51.2, meaning investors pay $51.2 for every $1 of annual earnings. The forward P/E is 104.3, reflecting analyst expectations for future earnings. Edwards Lifesciences operates in the Healthcare sector.
Does EW pay dividends?
Edwards Lifesciences does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for EW?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for EW is Buy. The average 12-month price target is $104.70, a 17.5% upside from the Oct 23, 2026 close of $89.07.
What is the market cap of EW?
As of the Oct 23, 2026 close, Edwards Lifesciences's market capitalization is $51.45B, classifying it as a large-cap company. Edwards Lifesciences operates in the Healthcare sector within the Medical Devices industry.